Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development
Abstract Negative symptoms have long been considered a core component of schizophrenia. Modern conceptualizations of the structure of negative symptoms posit that there are at least two broad dimensions (motivation and pleasure and diminished expression) or perhaps five separable domains (avolition,...
Guardado en:
Autores principales: | Gregory P. Strauss, Lisa A. Bartolomeo, Philip D. Harvey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6834fb18be19439db326edda7e32bb9b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials
por: Michel Sabe, et al.
Publicado: (2021) -
Intermittent theta burst stimulation for negative symptoms of schizophrenia—A double-blind, sham-controlled pilot study
por: Rémy Bation, et al.
Publicado: (2021) -
Thought disorder measured as random speech structure classifies negative symptoms and schizophrenia diagnosis 6 months in advance
por: Natália B. Mota, et al.
Publicado: (2017) -
Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
por: Aleksandr M. Reznik, et al.
Publicado: (2020) -
Learning stable and predictive network-based patterns of schizophrenia and its clinical symptoms
por: Mina Gheiratmand, et al.
Publicado: (2017)